Cargando…

Anti-Tumoral and Anti-Angiogenic Effects of Low-Diluted Phenacetinum on Melanoma

Melanoma is the most aggressive form of skin cancer and the most rapidly expanding cancer in terms of worldwide incidence. If primary cutaneous melanoma is mostly treated with a curative wide local excision, malignant melanoma has a poor prognosis and needs other therapeutic approaches. Angiogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuselier, Camille, Quemener, Sandrine, Dufay, Eleonore, Bour, Camille, Boulagnon-Rombi, Camille, Bouland, Nicole, Djermoune, El-Hadi, Devy, Jérôme, Martiny, Laurent, Schneider, Christophe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966719/ https://www.ncbi.nlm.nih.gov/pubmed/33747916 http://dx.doi.org/10.3389/fonc.2021.597503

Ejemplares similares

Low-diluted Phenacetinum disrupted the melanoma cancer cell migration
por: Fuselier, Camille, et al.
Publicado: (2019)

Dynamized ultra-low dilution of Ruta graveolens disrupts plasma membrane organization and decreases migration of melanoma cancer cell
por: Fuselier, Camille, et al.
Publicado: (2022)

Identification of TAX2 peptide as a new unpredicted anti-cancer agent
por: Jeanne, Albin, et al.
Publicado: (2015)

LRP-1 Matricellular Receptor Involvement in Triple Negative Breast Cancer Tumor Angiogenesis
por: Campion, Océane, et al.
Publicado: (2021)

Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide
por: Jeanne, Albin, et al.
Publicado: (2017)

Collagen-Based Medical Device as a Stem Cell Carrier for Regenerative Medicine
por: Aubert, Léa, et al.
Publicado: (2017)

Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor Immunity
por: Jeanne, Albin, et al.
Publicado: (2021)

Label-Free Infrared Spectral Histology of Skin Tissue Part II: Impact of a Lumican-Derived Peptide on Melanoma Growth
por: Brézillon, Stéphane, et al.
Publicado: (2020)

Label-Free Infrared Spectral Histology of Skin Tissue Part I: Impact of Lumican on Extracellular Matrix Integrity
por: Nannan, Lise, et al.
Publicado: (2020)

Mithramycin Exerts an Anti-Myeloma Effect and Displays Anti-Angiogenic Effects through Up-Regulation of Anti-Angiogenic Factors
por: Otjacques, Eléonore, et al.
Publicado: (2013)

PD-L1 Expression in 65 Conjunctival Melanomas and Its Association with Clinical Outcome
por: Lassalle, Sandra, et al.
Publicado: (2020)

Discoidin Domain Receptor 1 Expression in Colon Cancer: Roles and Prognosis Impact
por: Ben Arfi, Kaouther, et al.
Publicado: (2022)

Functional Interplay Between Collagen Network and Cell Behavior Within Tumor Microenvironment in Colorectal Cancer
por: Le, Cuong Cao, et al.
Publicado: (2020)

Chrysin-Induced Regression of Angiogenesis via an Induction of DNA Damage Response and Oxidative Stress in In Vitro and In Vivo Models of Melanoma
por: Sassi, Aicha, et al.
Publicado: (2023)

Biobanking of Fresh-Frozen Human Adenocarcinomatous and Normal Colon Tissues: Which Parameters Influence RNA Quality?
por: Galissier, Thibaut, et al.
Publicado: (2016)

LRP1 expression in colon cancer predicts clinical outcome
por: Boulagnon-Rombi, Camille, et al.
Publicado: (2018)

Apelin expression deficiency in mice contributes to vascular stiffening by extracellular matrix remodeling of the aortic wall
por: Romier, Beatrice, et al.
Publicado: (2021)

Elevated soluble Flt1 mediates an anti-angiogenic state in patients with ANCA-associated vasculitis
por: Le Roux, S, et al.
Publicado: (2010)

Assessment of Ovarian Tumor Growth in Wild-Type and Lumican-Deficient Mice: Insights Using Infrared Spectral Imaging, Histopathology, and Immunohistochemistry
por: Nizet, Pierre, et al.
Publicado: (2021)

Angiogenic signaling pathways and anti-angiogenic therapy for cancer
por: Liu, Zhen-Ling, et al.
Publicado: (2023)

Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment
por: Wohlfeil, Sebastian A., et al.
Publicado: (2022)

Sales for anti-angiogenic drugs
por: Ribatti, Domenico
Publicado: (2017)

Nephrotoxicity of Anti-Angiogenic Therapies
por: Van Wynsberghe, Margaux, et al.
Publicado: (2021)

The Classical Pink-Eyed Dilution Mutation Affects Angiogenic Responsiveness
por: Rogers, Michael S., et al.
Publicado: (2012)

Anti-Angiogenic and Anti-Metastatic Activity of Synthetic Phosphoethanolamine
por: Ferreira, Adilson Kleber, et al.
Publicado: (2013)

The Anti-Angiogenic and Anti-Proliferative Activity of Methyl Hydroxychalcone
por: Sahib, Hayder B
Publicado: (2022)

In vitro and in vivo combination of cepharanthine with anti-malarial drugs
por: Desgrouas, Camille, et al.
Publicado: (2014)

Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular Diseases
por: Lançon, Allan, et al.
Publicado: (2016)

Anti-Angiogenic Effect of Triptolide in Rheumatoid Arthritis by Targeting Angiogenic Cascade
por: Kong, Xiangying, et al.
Publicado: (2013)

Serum Angiogenic and Anti-angiogenic Markers in Pregnant Women with Placenta Percreta
por: Uyanıkoğlu, Hacer, et al.
Publicado: (2018)

The promise of anti-angiogenic cancer therapy
por: Oehler, M K, et al.
Publicado: (2000)

Biomarkers for Anti-Angiogenic Therapy in Cancer
por: Wehland, Markus, et al.
Publicado: (2013)

Anti-angiogenic alternatives to VEGF blockade
por: Khan, Kabir A., et al.
Publicado: (2015)

Reactive resistance to anti-angiogenic drugs
por: Bousquet, Guilhem, et al.
Publicado: (2015)

Anti-angiogenic therapies in brain metastases
por: Berghoff, Anna S., et al.
Publicado: (2018)

Limitations of Anti-Angiogenic Treatment of Tumors
por: Ribatti, Domenico, et al.
Publicado: (2019)

Anti-angiogenic therapy for ovarian cancer
por: García García, Yolanda, et al.
Publicado: (2020)

Mechanisms of resistance to anti-angiogenic treatments
por: Pezzella, Francesco
Publicado: (2019)

Anti-angiogenic therapies in the management of glioblastoma
por: Schulte, Jessica D., et al.
Publicado: (2021)

Anti-tumor and Anti-angiogenic Ergosterols from Ganoderma lucidum
por: Chen, Shaodan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fgslp5gu99qq3vmi1bmbpq8fa9